Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Federal Trade Commission
Fish and Richardson
Farmers Insurance
Healthtrust
Teva
Julphar
Covington
Daiichi Sankyo
Novartis

Generated: January 20, 2018

DrugPatentWatch Database Preview

NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Naproxen Sodium And Pseudoephedrine Hydrochloride, and what generic alternatives are available?

Naproxen Sodium And Pseudoephedrine Hydrochloride is a drug marketed by Dr Reddys Labs Inc and Perrigo and is included in two NDAs.

The generic ingredient in NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE is naproxen sodium; pseudoephedrine hydrochloride. There are forty-two drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the naproxen sodium; pseudoephedrine hydrochloride profile page.
Summary for NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE
Drug patent expirations by year for NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE

US Patents and Regulatory Information for NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dr Reddys Labs Inc NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE naproxen sodium; pseudoephedrine hydrochloride TABLET, EXTENDED RELEASE;ORAL 077381-001 Sep 27, 2006 OTC No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Perrigo NAPROXEN SODIUM AND PSEUDOEPHEDRINE HYDROCHLORIDE naproxen sodium; pseudoephedrine hydrochloride TABLET, EXTENDED RELEASE;ORAL 076518-001 Mar 17, 2004 OTC No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
US Department of Justice
Chubb
Novartis
Boehringer Ingelheim
UBS
Merck
Healthtrust
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot